Midas+ Solutions, a healthcare company specializing in quality management, asked C-level healthcare executives to define population health management.
Midas+ Solutions, a healthcare company specializing in quality management, conducted a poll of C-level healthcare executives at it's annual symposium. Representing more than 480 hospitals, the executives were asked to present their perspective on population health management and the factors that define it. The gist of most definitions was what is reverberating across different healthcare systems: facilitating care across the healthcare continuum and highest quality care at the lowest cost.
The executives ranked the factors in the following order:
Based on their responses, most healthcare organizations are already on top of the game: 65% responders were confident that their organization will deliver fully-scaled population health management programs within 5 years, while 16% indicated that they active population management programs in their organization.
Read more at HIStalk PRACTICE: http://bit.ly/1Iqg3yD
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
2 Commerce Drive
Cranbury, NJ 08512